SCHEMBL6249095

SCHEMBL6249095

O=c1[nH]cccc1-c1csc(-c2ccccn2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 5/20 0.50
▸ KDM4E B2RXH2 3/20 0.50
▸ MAPT P10636 3/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ PKM P14618 1/20 0.50
▸ GFER P55789 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ KDM4C Q9H3R0 1/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ CYP19A1 P11511 4/20 0.49
▸ PDE10A Q9Y233 1/20 0.49
▸ IDO1 P14902 1/20 0.43
▸ CDK5 Q00535 4/20 0.41
▸ CDK5R1 Q15078 4/20 0.41
▸ CYP1A1 P04798 2/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ CYP1B1 Q16678 2/20 0.39
▸ NPC1 O15118 3/20 0.39
▸ GBA1 P04062 1/20 0.39
▸ MIF P14174 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2096438 0.82 PRKCI (0.47) RAB9AKDM4EMAPTALDH1A1PKM
SCHEMBL6242058 0.81 CDK5 (0.57) RAB9AKDM4EMAPTCYP19A1CDK5
SCHEMBL6200227 0.77 AR (0.52) RAB9AKDM4EMAPTALDH1A1PKM
SCHEMBL23204441 0.76 CDK1 (0.53) RAB9AMAPTCDK5CDK5R1SMN1; SMN2
SCHEMBL1741719 0.76 CYP19A1 (0.79) RAB9AKDM4EMAPTALDH1A1PKM
SCHEMBL8801090 0.72 PRKCI (0.46) RAB9AKDM4EMAPTALDH1A1KDM4C
SCHEMBL17014755 0.71 RAB9A (0.66) RAB9AKDM4EMAPTALDH1A1PKM
SCHEMBL17873568 0.71 AR (0.54) RAB9AKDM4EMAPTALDH1A1MAPK1
SCHEMBL21834624 0.70 HTR3A (0.39) RAB9AKDM4EMAPTALDH1A1CDK5
SCHEMBL11017741 0.70 MEN1 (0.74) RAB9AKDM4EMAPTALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1575947-A1 2-OXOPYRIDIN-3-YL THIA(DI)AZOLE DERIVATIVES FOR USE IN THE TREATMENT OF CELL PROLIFERATION AND APOPTOSIS RELATED DISEASES Amgen Inc. (US) 2005-09-21 — — EP disclosed
WO-2004060890-A1 2-OXOPYRIDIN-3-YL THIA (DI) AZOLE DERIVATES FOR USE IN THE TREATMENT OF CELL PROLIFERATION AND APOPTOSIS RELATED DISEASES AMGEN INC. (US) 2004-07-22 — — WO disclosed
Send feedback